MedMarket Diligence
provides tactical information and insight to the medical products,
investment and other industries on the status and outlook for advanced
medical technologies. The company publishes
a range of medical technology market and
assessment
Reports
and the Medtech
Startups Database. MedMarket Diligence provides market
intelligence for competitive advantage to the world's leading and
emerging medtech companies.
Patrick Driscoll founded MedMarket Diligence in October 2001. Mr. Driscoll has over 25 years experience analyzing and writing on medical technology markets, encompassing medical devices, biotech and biopharmaceuticals. He co-founded Medtech Insight and
as a principal with Medical Data International directed the
custom research, syndicated reports and database research
businesses. Mr. Driscoll received a BS from the University of Dallas, and an MBA from the University of New Hampshire's Whittemore School of Business & Economics.
Email:
patrick mediligence com.
Dona Watson is a staff writer and analyst for
MedMarket Diligence. Ms. Watson has researched, analyzed and
written on numerous medical technology markets and has an extensive editorial background and focus serving the information needs of the industry.
She was most recently Editor of the previously published
MedMarkets newsletter and has served in editorial, analyst and writer positions for the MedPro Month publication of Medical Data International, as well as Nicholas Communications, and Biomedical Business International. In addition, Ms. Watson was president of Catalyst Communications, where she was publisher for an industry newsletter devoted to reimbursement of medical products. Ms. Watson received a BA from Vanguard University.
Email: dona mediligence com.
Contact us:
MedMarket Diligence, LLC 51 Fairfield
Foothill Ranch, CA 92610
USA tel: +1.949.859.3401
tel: +1.949.891.1753 Google Voice
toll-free (in the U.S.): 1-866-820-1357
fax: 949.837.4558
[
